chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 33-year-old female patient (gravida 2, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 026L20A) for COVID-19 vaccination.     The patient's past medical history included Gestational hypertension (Single umblical artery) on 02-Feb-2019, Spontaneous abortion (on an unknown date of April 2018.) in April 2018 and Pregnancy (Live full term birth.) on 02-Feb-2019. Concurrent medical conditions included Alcohol use (3 drinks a year). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), DOCUSATE SODIUM (COLACE), MAGNESIUM and MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 05-Jan-2021 at 12:45 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021 at 9:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 18-Aug-2020 and the estimated date of delivery was 25-May-2021. On 05-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twentieth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Full-term. For neonate 1, the birth weight was 3600 grams (7lbs 15oz). The outcome was reported as Term Birth w/o Complications. there was a complication of Complete placenta Previa during this pregnancy. On 05-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Sep-2020, Pregnancy test: positive (Positive) Positive. On an unknown date, Ultrasound scan: normal (normal) Normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On an unspecified date, lab test also included genetic testing; however, result was normal.  Number of fetus was found to be one.   Patient delivered a live full-term baby on ??-???-2021. Patient had no complications related to pregnancy and the patient gave birth to male baby with no abnormalities.  Treatment information was not provided.   This case was linked to MOD-2021-237477 (Parent-Child Link).   See case MOD-2021-237477 for details regarding the child case.  Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Follow-up document included outcome of pregnancy and patient demographics (gender and weight).
Redness and swelling at lt anterior & anteromedial aspect of thigh which increased in size in 24 hrs. No tenderness, no d/c, no h/o fever, SOB or cough. Tx: pt was seen at hospital ER & started on SEPTRA and KEFLEX on 5/5/11. 5/20/11 completely resolved.
Menactra was administered IM Lt deltoid. Pt became diaphoretic and pale. Nurse turned to get water from sink (next to pt.) Pt. fell out of chair onto floor hitting his head on wall or floor. The patient did not move for 5 seconds then he had involuntary movement in shoulders and arms and raised himself by placing hands on floor. He was assisted to a chair. Dr (health dept's health officer) arrived. He determined that pt. fainted. Mother was called to the room.
Information has been received from a registered nurse referring to a 2 year old patient of unknown gender. There was no medical history or drug reaction/allergies reported. The patient was vaccinated with three doses of RECOMBIVAX HB (dose, lot# and route were unknown) on 29-OCT-2008, 03-DEC-2008 and 16-FEB-2009, respectively, which was an inappropriate schedule for this vaccine. No adverse effects were reported. The reporter stated that the patient received the vaccines in another location so lot information was not available. Additional information is not expected since the reporter refused to be contacted.
This spontaneous report was received from a health professional refers to a patient of unknown age and gender. The patient's medical history and concomitant medications were not reported. On 09-SEP-2016, the patient was vaccinated with VAQTA (lot # L015460, expiry date: 20-JUL-2017) for prophylaxis (dose and route was not reported), which was stored improperly.
Information has been received from a physician concerning a female who was vaccinated with GARDASIL (Lot #, dose, and site not reported). Subsequently the "patient experienced extreme pain in the arm, nausea, dizziness and vomiting. The pain was so bad that she went to the ER". No additional information was provided. Additional information is not expected.
The patient received a fifth dose of the Covid-19 vaccine 12 days after receiving his fourth dose (on 4/13/22).  The patient did not seek  any other medical contact until 5/16/22, where he arrived to the emergency department for left foot swelling, and  Afib rvr.
fever spiked to 101 degrees; developed a headache; was tired; her RIGHT arm was sore; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th July 2021, the patient received the 1st dose of Shingrix (intramuscular). On 7th July 2021, 3 hrs after receiving Shingrix, the patient experienced pain in arm. On 8th July 2021, the patient experienced fever, headache and tiredness. The patient was treated with ibuprofen (Advil). On 8th July 2021, the outcome of the pain in arm was recovered/resolved. On 9th July 2021, the outcome of the headache and tiredness were recovered/resolved. On an unknown date, the outcome of the fever was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, fever, headache and tiredness to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient herself. The patient received 1st dose of Shingrix and about 3 hours later her right arm was sore, which was resolved next day. On the next day in the afternoon her fever spiked to 101 degrees, she developed a headache and was tired. The fever was down to 99, but not completely resolved.  The reporter stated that her pharmacist instructed her to take advil for the fever. The reporter did not consent to follow-up.
1. Loud & heavy ringing in right ear.  Moderate ringing in left ear. This continues 1-2 times per day. 2. Headache/Malaise - Intermittent  An order was issued on 10/20/2021 and signed by organization leadership. This signed order mandated all employees to submit to vaccination for Covid-19.   I complied, with serious reservations and under duress, to this order on 10/25/2021. My voluntary submission to the Influenza vaccination run by the company on 11/1/2020 resulted in illness that caused another employee to grant me paid Medical sick leave a few days later to get over this negative allergic reaction. The Covid-19 vaccination has caused me to have headaches, lethargy, and most troubling - severe ringing in both ears that is painful and intiminitely debilitating. I could not report to the employer because of a hostile work environment created by this mandate.
Given expired vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Given expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.
had a high fever went up to 102; had some spots around arms & waist for about 10 days; had diarrhea & difficulty swallowing; had no appetite; had fatigue for about 4 days & slept most of the day for  2 days; no stool cult done;
At the time of the J&J vaccine I was 6 weeks pregnant.  3 days after my J&J vaccine, I suffered a miscarriage.
Covid arm about 8" long x 3". Red rash. Not particularly itchy or bothersome. May have appeared earlier, but only noticed because I saw it in mirror
This spontaneous report as received from an office manager (via company representative) refers to her daughter of unknown age. In May 2004 (reported as 10 years ago) the patient was vaccinated with a dose of VARIVAX (dose, lot # and route not reported) for prevention of chickenpox. Office manager stated her daughter received VARIVAX and had an adverse experience with it (approximately in 2004). The patient "broke out in a large area around the injection site". The patient has had the same adverse experience with other unspecified vaccines. It was unknown what those other vaccines were. On an unknown date the patient recovered. Relatedness between the therapy and the event was not reported. Additional information has been requested.
Discharge Provider: MD Primary Care Provider: DO Admission Date: 6/21/2023 Discharge Date: 6/26/2023  DETAILS OF HOSPITAL STAY:   Clinical Narrative: 90-year-old gentleman brought into emergency room by family for shortness of breath cough fever and confusion.  He was brought into the emergency department by family, and height hypoxemia at 88% requiring 2 L of oxygen.  His chest x-ray showed improving bilateral airspace disease compared to recent prior chest x-ray COVID test was positive.   He was treated with IV dexamethasone 6 mg daily as well as cefepime and doxycycline.  By discharge he was back to his baseline status breathing comfortably on 2 L of oxygen (which is his home dose)  with his oxygen saturation in the upper 90s.   e was converted to oral prednisone taper to complete a total 10 day course. On day of discharge, , cxr showed slight worsening of left basilar infiltrate His antibiotics will be continued for an additional 4 days to complete a 10 day course.   He will discharge to home with home health care
Pt is a HCP. His wife noticed that he had discrete circular patches of hair missing from scalp as his wife is shorter she had not noticed before, until the 16th when he was going down the stairs in front of her. The spots are not puritic nor scaley consistent with other entities. Presentation is consistent with alopicia ereata though autoimmune can be brought on by immunization as has been demonstrated by the recombinant DNA Hep B immunization.
Shivers during the night.  Sore arm at injection site and general body aches in the morning.  Mild brain fog until about 1pm the next day.
Cough, weakness, appetite change, abdonimal pain, back pain, neck pain, headaches
Administered Tdap and MENACTRA to client. After sitting for a couple of minutes client stood up by mother while sibling was receiving vaccines and became lightheaded falling to the floor. Client did not lose consciousness and immediately got up with some assistance.  Client reported that she felt fine but did complain of pain behind left ear. No redness or swelling was noted. After drinking juice client again reported she felt fine and walked out of clinic with mother accompanied by nurse.
flu-like symptoms; lethargic; uncomfortable; upset stomach; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), LETHARGY (lethargic), DISCOMFORT (uncomfortable) and ABDOMINAL DISCOMFORT (upset stomach) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), LETHARGY (lethargic), DISCOMFORT (uncomfortable) and ABDOMINAL DISCOMFORT (upset stomach). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), LETHARGY (lethargic), DISCOMFORT (uncomfortable) and ABDOMINAL DISCOMFORT (upset stomach) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On 30-NOV-2017, the patient was vaccinated with improperly stored dose of PROQUAD lot # N016089, expiration date 22-NOV-2019 (also reported as 22-NOV-2018), therapy type RHA for prophylaxis. No adverse effects were reported. The PROQUAD underwent a temperature excursion of -14 to -10 degrees Celsius for 96 minutes. There was no previous temperature excursion. Data logger was involved. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1801USA002684: US-009507513-1801USA002685: US-009507513-1801USA002686:
?Covid Arm?. After injection site sweeping and pain went away 5 days later my upper arm was red and itchy and slightly warm to touch.  It is still a little pink and itchy but better
Swelling and drooping of right eyelid. Painful to touch. Turned into a stye after several days. Believe it could be a reaction to a dermal filler.
Chills; Very high anxiety; I felt like I taste something; Low energy; Sore arm; This is a spontaneous report received from a contactable reporter (consumer). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), via an unspecified route of administration, administration date 19Feb2021 (Lot number: EN9581) as dose 1, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Cortisone, reactions: "tremors and shakes", notes: Almost for a whole year and "agoraphobic"; Iodine dye for kidney test, reaction: "Hard time breathing". The following information was reported: CHILLS (non-serious), outcome "unknown", described as "Chills"; ANXIETY (non-serious), outcome "unknown", described as "Very high anxiety"; DYSGEUSIA (non-serious), outcome "unknown", described as "I felt like I taste something"; ASTHENIA (non-serious), outcome "unknown", described as "Low energy"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Sore arm".   Additional information: The patient stated to be going for my second shot, but the concern was the first shot and the side effects. The patient reported to had the chills and very high anxiety. The patient even felt like when had my shot, little bit after, felt like patient taste something and anyhow and low energy and this sore arm. The patient stated that the concern was though when had a cortisone shot, patient had the tremors and shakes. The patient would have that almost for a whole year that patient become agoraphobic, it got so bad, but patient was able to manage. The patient was able to get out and do what has to be done but the other one was patient had a Iodine dye, kidney test and of course that was injectable and had a hard time breathing. The patient was concern for the second shot. The patient was querying if patient would have to be worried because patient did have those two different episodes. The patient further stated, that the concern is when patient got anxiety with this first shot, it brought (also reported as broke) all back to how patient felt when patient had cortisone shot although patient didn't shake. Patient did get anxiety.   No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning a female patient who on unspecified dates was vaccinated with all  3 doses of GARDASIL (lot numbers not reported). After the vaccinations the physician did a test for human papillomavirus (HPV) and on the first test she tested negative, however for the second test she tested positive for HPV type 16. Unspecified medical attention was sought. The outcome of the patient was not reported. Additional information has been requested.
Bivalent Covid vaccine on Monday, Thursday evening I was in the ER with Pancreatitis. I have no history or family history of Pancreatitis, I do not drink alcohol, I had my gallbladder removed in 2021, and my endocrinologist checked that none of my medications could cause Pancreatitis. The ER recommended I follow up with a GI doctor, she found nothing.
throat closing; feeling dizzy; weak; This spontaneous case was reported by a patient and describes the occurrence of THROAT TIGHTNESS (throat closing), DIZZINESS (feeling dizzy) and ASTHENIA (weak) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A and 025C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-May-2021, the patient experienced THROAT TIGHTNESS (throat closing), DIZZINESS (feeling dizzy) and ASTHENIA (weak). At the time of the report, THROAT TIGHTNESS (throat closing), DIZZINESS (feeling dizzy) and ASTHENIA (weak) outcome was unknown.            No relevant concomitant medication was reported. Treatment information was not provided.
This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the left arm on 23Mar2021 at 14:15 (at the age of 52-years-old) as a single dose for COVID-19 immunization. Medical history included asthma and obesity. The patient had allergy to shellfish. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and unspecified supplements, all for unknown indications from unknown dates. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Mar2021 at 01:00, the patient experienced pain at injection site radiating into shoulder blade. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events pain at injection site radiating into shoulder blade and pain at injection site. The clinical outcomes of the events pain at injection site radiating into shoulder blade and pain at injection site were recovered on an unknown date in Mar2021. No follow-up attempts are possible. No further information is expected.
Her face, on the bottom of her right side of face is swollen; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient). A 82-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date (at the age of 82-year-old) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that, the caller was called about the Pfizer vaccine and reclarified as the Covid 19 Vaccine. The caller stated that, she had the first shot two and half weeks ago and this Thursday, she was due for the second shot. She stated that, her face, on the bottom of her right side of face was swollen. It probably started, then reclarified, within the first week, she was not sure of what date. Stated that, the caller was concerned about swelling. Stated that, she wanted to know what to be done about that, that's why she was called and waited an hour on hold and queried, was it something that medication can cure or will it be permanent. Stated that, the caller would like to know who would give the advice. She stated that, she has a primary doctor who did not know what to do about her swelling and the doctor told her to call the company. Stated that, there must be other people who have this and how to deal with it. Stated that, the caller asked to be transferred to a different department. The caller stated that, this was a total waste of time, she was thrilled with the vaccine. However, she would like the swelling in her face to go down and she has no idea how to make it go down or how to take care of it. Stated that, she read about swollen lymph nodes on her paperwork, she questioned whether this was a swollen lymph node. Stated that, also on the paperwork she said more serious that swelling of face and throat. Stated that, her throat was not swollen, but her face was. She guessed she would call her primary doctor. Stated that, she thinks she was more interested in calling her doctor. Stated that, she was hoped as Pfizer would tell her how to make it go away with ice, a prescription or how to deal. The caller stated that, she got none of that for an hour, from 30th down to 1. The outcome of the event was unknown.  No follow-up attempts are possible, information about lot/batch cannot be obtained.
PT DENIED HAVING A REACTION TO ANY VACCINE PREVIOUSLY AND DENIED HAVING AN ALLERGY TO PEG OR POLYSORBATE. AFTER RECEIVING THE VACCINE AT 2:43PM PT STATED HE FELT DIZZY AND WOULD LIKE TO SIT DOWN. I WALKED HIM TO THE PATIENT CARE AREA AND SAT BESIDE HIM FOR HIS 15 MIN WAITING PERIOD. AT 2:45PM PATIENT STARTED TO SNORE LOUDLY AND COULD NOT BE WAKEN UP. CALL 911 . FTER PATIENT WAS ON THE GROUND HE GAIN CONSCIOUNESS. HE STATED HE TOOK A GREAT NAP AND WAS ABLE TO TELL ME HIS NAME, DOB, MY NAME AND WHERE HE WAS AT. HE BP WAS LOW UPON CHECKING THE FIRST TIME IT SPB WAS 74 THEN WHEN EMS ARRIVED WAS 94/60 WITH A PULSE OF 80BPM. HE ALSO STATED HE DID NOT WANT EMS TO TAKE HIM TO THE HOSPITAL. EMS ARRIVED AT 2:52PM. AT 4:07 PM EMS CAME BACK TO THE PHARMACY AND STATED THE PATIENT REFUSED TO GO TO THE HOSPITAL AND FOR HIPPA REASONS COULD NOT SHARE WHAT WAS GOING ON. CALLED THE PT LATER THIS EVENING AND HE SAYS HE IS DOING FINE AND HAS HAD NO FURTHER COMPLICATIONS.